Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Quarterly results
Inv. presentation

Outlook Therapeutics, Inc. (ONS) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 4 Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 370,282 options to buy @ $0.24, valued at $88.9k
10/05/2023 4 Haller Julia A (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 210,225 options to buy @ $0.24, valued at $50.5k
10/05/2023 4 Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 191,113 options to buy @ $0.24, valued at $45.9k
10/05/2023 4 Auffarth Gerd (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 210,225 options to buy @ $0.24, valued at $50.5k
10/05/2023 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 358,337 options to buy @ $0.24, valued at $86k
10/05/2023 4 Sukhtian Faisal Ghiath (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 372,671 options to buy @ $0.24, valued at $89.4k
10/05/2023 4 HILZINGER KURT J (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 286,670 options to buy @ $0.24, valued at $68.8k
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/31/2023 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 41,065 options to buy @ $1.05, valued at $43.1k
03/31/2023 4 Haller Julia A (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 41,065 options to buy @ $1.05, valued at $43.1k
03/31/2023 4 Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 41,065 options to buy @ $1.05, valued at $43.1k
03/31/2023 4 Auffarth Gerd (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 41,065 options to buy @ $1.05, valued at $43.1k
03/31/2023 4 Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 41,065 options to buy @ $1.05, valued at $43.1k
03/31/2023 4 Sukhtian Faisal Ghiath (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 41,065 options to buy @ $1.05, valued at $43.1k
03/31/2023 4 THURMAN RANDY H (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 41,065 options to buy @ $1.05, valued at $43.1k
03/31/2023 4 HILZINGER KURT J (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 41,065 options to buy @ $1.05, valued at $43.1k
01/24/2023 4 Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Sold 267,000 shares @ $1.11, valued at $296.4k
01/19/2023 4 Evanson Jeff (Chief Commercial Officer) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Sold 27,162 shares @ $1.31, valued at $35.6k
Sold 33,738 shares @ $1.25, valued at $42.2k
Sold 103,255 shares @ $1.22, valued at $126k
12/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2022 4 Sukhtian Faisal Ghiath (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Bought 30,000 shares @ $1.29, valued at $38.7k
10/11/2022 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Bought 29,743 shares @ $1.29, valued at $38.4k
Bought 3,600 shares @ $1.27, valued at $4.6k
10/07/2022 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 71,998 options to buy @ $1.25, valued at $90k
10/07/2022 4 HILZINGER KURT J (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 57,598 options to buy @ $1.25, valued at $72k
10/07/2022 4 Gangolli Julian S (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 74,398 options to buy @ $1.25, valued at $93k
10/07/2022 4 Haller Julia A (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 42,239 options to buy @ $1.25, valued at $52.8k
10/07/2022 4 Auffarth Gerd (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 42,239 options to buy @ $1.25, valued at $52.8k
10/07/2022 4 Sukhtian Faisal Ghiath (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 74,878 options to buy @ $1.25, valued at $93.6k
10/07/2022 4 Huang Andong (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 38,399 options to buy @ $1.25, valued at $48k
10/05/2022 4 HILZINGER KURT J (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Bought 95,541 shares @ $1.29, valued at $123.2k
Bought 15,662 shares @ $1.23, valued at $19.3k
10/03/2022 4 HILZINGER KURT J (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Bought 13,800 shares @ $1.19, valued at $16.4k
Bought 33,199 shares @ $1.26, valued at $41.8k
Bought 41,798 shares @ $1.25, valued at $52.2k
08/15/2022 4 Haller Julia A (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.15, valued at $28.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy